Revealing the molecular mystery of human liver cells

byUniversity Health Network(L to R) Drs. Sonya MacParland and Ian McGilvray, scientists in University Health Network's Transplant Program, led the research into first map of the human liver

Updated on: December 18,2023 15

Revealing the molecular mystery of human liver cells

byUniversity Health Network(L to R) Drs. Sonya MacParland and Ian McGilvray, scientists in University Health Network's Transplant Program, led the research into first map of the human liver

Updated on:December 18,2023 15

Liver Biopsy: Understanding Test Purpose and Results

ByJames Myhre & Dennis Sifris, MDPublished on October 11, 2023Medically reviewed byJay N. Yepuri, MDA liverbiopsyis a medical procedure that removes a small pie

Updated on: December 21,2023 13

Liver Biopsy: Understanding Test Purpose and Results

ByJames Myhre & Dennis Sifris, MDPublished on October 11, 2023Medically reviewed byJay N. Yepuri, MDA liverbiopsyis a medical procedure that removes a small pie

Updated on:December 21,2023 13

Telemedicine treatment for HCV in people with opioid use disorder more than twice as successful as offsite referral

by Ellen Goldbaum,University at Buffalo“Telemedicine leads to high patient retention in care and cure within this population,” says Andrew H. Talal, MD, professor of medicine in the Jacobs Schoo

Updated on: January 04,2024 6

Telemedicine treatment for HCV in people with opioid use disorder more than twice as successful as offsite referral

by Ellen Goldbaum,University at Buffalo“Telemedicine leads to high patient retention in care and cure within this population,” says Andrew H. Talal, MD, professor of medicine in the Jacobs Schoo

Updated on:January 04,2024 6

Tiny model organs detect liver toxicity of new drugs

by Patricia DeLacey,University of MichiganGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.01.019Researchers are working to improve drug testing to en

Updated on: January 04,2024 11

Tiny model organs detect liver toxicity of new drugs

by Patricia DeLacey,University of MichiganGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.01.019Researchers are working to improve drug testing to en

Updated on:January 04,2024 11

Smartphones could be used to monitor liver disease patients at home

byUniversity College LondonAssessment of bilirubin levels in patients with cirrhosis via forehead, sclera and lower eyelid smartphone images. Credit:PLOS Digital Health(2023). DOI: 1

Updated on: January 05,2024 14

Smartphones could be used to monitor liver disease patients at home

byUniversity College LondonAssessment of bilirubin levels in patients with cirrhosis via forehead, sclera and lower eyelid smartphone images. Credit:PLOS Digital Health(2023). DOI: 1

Updated on:January 05,2024 14

Mini livers recreate real environment for drug discovery

byTechnical University of DenmarkSchematic of the liver MPS hydrogel chip. Cells or spheroids are seeded by pipetting directly into each of the three culture cavities, without or with addition o

Updated on: January 06,2024 17

Mini livers recreate real environment for drug discovery

byTechnical University of DenmarkSchematic of the liver MPS hydrogel chip. Cells or spheroids are seeded by pipetting directly into each of the three culture cavities, without or with addition o

Updated on:January 06,2024 17

How liver cells become scarring, and worse

by Sanford-Burnham PrebysIn this stained micrograph, strands of activated hepatic stellate cells (blue) create characteristic “chicken wire” fibrosis in the liver and, in this case, a condition called

Updated on: January 25,2024 16

How liver cells become scarring, and worse

by Sanford-Burnham PrebysIn this stained micrograph, strands of activated hepatic stellate cells (blue) create characteristic “chicken wire” fibrosis in the liver and, in this case, a condition called

Updated on:January 25,2024 16

New hope for patients with non-alcoholic fatty liver disease

byUniversity of MontrealCredit:Metabolism(2023). DOI: 10.1016/j.metabol.2023.155736Non-alcoholic fatty liver disease (NAFLD) is a major health problem affecting approximately 30% of

Updated on: January 25,2024 12

New hope for patients with non-alcoholic fatty liver disease

byUniversity of MontrealCredit:Metabolism(2023). DOI: 10.1016/j.metabol.2023.155736Non-alcoholic fatty liver disease (NAFLD) is a major health problem affecting approximately 30% of

Updated on:January 25,2024 12

Researchers reveal uncharted liver-focused pathway in gene therapy immune responses

byIndiana University School of MedicineGraphical Abstract. Credit:Molecular Therapy(2023). DOI: 10.1016/j.ymthe.2023.11.029Indiana University School of Medicine researchers have unco

Updated on: January 26,2024 12

Researchers reveal uncharted liver-focused pathway in gene therapy immune responses

byIndiana University School of MedicineGraphical Abstract. Credit:Molecular Therapy(2023). DOI: 10.1016/j.ymthe.2023.11.029Indiana University School of Medicine researchers have unco

Updated on:January 26,2024 12

Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing

by Sichuan International Medical Exchange and Promotion AssociationThe intricate immune microenvironment, tumor cell plasticity, and dynamics of tumor evolution pose daunting challenges to the definit

Updated on: January 26,2024 17

Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing

by Sichuan International Medical Exchange and Promotion AssociationThe intricate immune microenvironment, tumor cell plasticity, and dynamics of tumor evolution pose daunting challenges to the definit

Updated on:January 26,2024 17

Markers of inflammation can predict 180-day mortality in cirrhosis

by Elana GotkineFor patients with newly diagnosed cirrhosis, markers of inflammation can predict 180-day mortality, but not liver-related admissions, according to a study published online Nov. 16 in&n

Updated on: January 29,2024 16

Markers of inflammation can predict 180-day mortality in cirrhosis

by Elana GotkineFor patients with newly diagnosed cirrhosis, markers of inflammation can predict 180-day mortality, but not liver-related admissions, according to a study published online Nov. 16 in&n

Updated on:January 29,2024 16

Researchers identify a potential therapeutic target against cirrhosis and liver inflammation

by University of BarcelonaA new study by a team of the University of Barcelona could promote the design of drugs to treat these pathologies. Credit: University of BarcelonaThe RNF41 protein could

Updated on: January 29,2024 12

Researchers identify a potential therapeutic target against cirrhosis and liver inflammation

by University of BarcelonaA new study by a team of the University of Barcelona could promote the design of drugs to treat these pathologies. Credit: University of BarcelonaThe RNF41 protein could

Updated on:January 29,2024 12